Cargando…
Novel Monoclonal Antibody Therapy in a Patient With Treatment-Refractory Warm Autoimmune Hemolytic Anemia
In autoimmune hemolytic anemia (AIHA), hemolysis is the hallmark symptom. Cold agglutinin disease (CAD) and warm autoimmune hemolytic anemia (wAIHA) are the two major forms of AIHA. Hemolysis is complement dependent in CAD, whereas wAIHA is a partially complement-mediated disorder. At the time of wr...
Autores principales: | Tahhan, Fadi, Huynh, Brandon, Xu, Prissilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209335/ https://www.ncbi.nlm.nih.gov/pubmed/35747120 http://dx.doi.org/10.7759/cureus.26051 |
Ejemplares similares
-
Serological Blood Group Discrepancy and Cold Agglutinin Autoimmune Hemolytic Anemia Associated With Novel Coronavirus
por: Raghuwanshi, Babita
Publicado: (2020) -
Hyperhemolysis in the Setting of Mixed-Autoimmune Hemolytic Anemia: A Rare Complication of COVID-19
por: Narula, Sonya, et al.
Publicado: (2021) -
Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy
por: Ma, Kim, et al.
Publicado: (2016) -
Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
por: Liu, Bainan, et al.
Publicado: (2013) -
Educational Case: Warm Autoimmune Hemolytic Anemia
por: Arays, Ruta, et al.
Publicado: (2020)